Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes (Q34718312): Difference between revisions

From Wikidata
Jump to navigation Jump to search
Browse history interactively
← Older edit
Charles Matthews (talk | contribs)
4,164,137 edits
‎Added reference to claim: instance of (P31): review article (Q7318358), #quickstatements; #temporary_batch_1612456617892
‎Removed claim: full work available at URL (P953): https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf, дублирующееся значение / duplicate value
 
(28 intermediate revisions by 6 users not shown)
label / enlabel / en
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes.
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
label / nllabel / nl
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes.
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes
label / astlabel / ast
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes.
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes
description / endescription / en
scientific article
scientific article published on April 1, 2011
description / ptdescription / pt
artigo científico
artigo científico publicado em 1 de abril de 2011
description / csdescription / cs
vědecký článek
vědecký článek publikovaný 1. dubna 2011
description / pt-brdescription / pt-br
artigo científico
artigo científico (publicado na 2011)
description / srdescription / sr
научни чланак
научни чланак објављен 1. април 2011.
description / nldescription / nl
wetenschappelijk artikel
wetenschappelijk artikel gepubliceerd op 1 april 2011
description / trdescription / tr
bilimsel makale
1 Nisan 2011'de yayımlanmış bilimsel makale
description / jadescription / ja
2011年の論文
2011年の学術論文
description / svdescription / sv
vetenskaplig artikel
vetenskaplig artikel publicerad den 1 april 2011
description / yuedescription / yue
2011年論文
2011年學術文章
description / esdescription / es
artículo científico publicado en 2011
artículo científico publicado el 1 de abril de 2011
description / pldescription / pl
artykuł naukowy
artykuł naukowy opublikowany 1 kwietnia 2011
description / zh-hansdescription / zh-hans
2011年论文
2011年学术文章
description / sqdescription / sq
artikull shkencor
artikull shkencor i botuar më 1 prill 2011
description / dedescription / de
wissenschaftlicher Artikel
im 1. April 2011 veröffentlichter wissenschaftlicher Artikel
description / dadescription / da
videnskabelig artikel
videnskabelig artikel offentliggjort den 1. april 2011
description / nandescription / nan
2011 nî lūn-bûn
2011 nî ê lūn-bûn
description / itdescription / it
articolo scientifico
articolo scientifico pubblicato il 1 aprile 2011
description / zh-hantdescription / zh-hant
2011年論文
2011年學術文章
description / videscription / vi
bài báo khoa học
bài báo khoa học xuất bản ngày 1 tháng 4, 2011
description / rudescription / ru
научная статья
научная статья опубликованная 1 апреля 2011 г.
description / frdescription / fr
article scientifique
article scientifique publié le 1 avril 2011
description / skdescription / sk
vedecký článok
vedecký článok publikovaný 1. apríla 2011
description / bgdescription / bg
научна статия
научна статия, публикувана на 1 април 2011 г.
description / wuudescription / wuu
2011年论文
2011年学术文章
description / zhdescription / zh
2011年论文
2011年學術文章
description / ltdescription / lt
mokslinis straipsnis
mokslinis straipsnis, publikuotas 2011 m. balandžio 1 d.
description / fadescription / fa
 
مقالهٔ علمی
description / urdescription / ur
 
سائنسی مضمون
description / sldescription / sl
 
znanstveni članek objavljen 1. april 2011
description / tg-latndescription / tg-latn
 
maqolai ilmiy
description / iddescription / id
 
artikel ilmiah
Property / publication date: 1 April 2011 / reference
 
stated in: PubMed Central
retrieved: 4 February 2021
Timestamp+2021-02-04T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / publication date: 1 April 2011 / reference
 
stated in: PubMed Central
retrieved: 26 October 2022
Timestamp+2022-10-26T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / publication date: 1 April 2011 / reference
 
stated in: PubMed Central
retrieved: 18 January 2024
Timestamp+2024-01-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / instance of: review article / reference
 
stated in: PubMed
retrieved: 18 January 2024
Timestamp+2024-01-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / instance of: review article / reference
stated in: PubMed Central
retrieved: 13 March 2019
Timestamp+2019-03-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / instance of: review article / reference
stated in: PubMed Central
retrieved: 14 March 2019
Timestamp+2019-03-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / instance of: review article / reference
stated in: PubMed
retrieved: 24 March 2019
Timestamp+2019-03-24T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / instance of: review article / reference
stated in: PubMed
retrieved: 17 September 2019
Timestamp+2019-09-17T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / instance of: review article / reference
stated in: PubMed
retrieved: 2 October 2019
Timestamp+2019-10-02T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / instance of: review article / reference
stated in: PubMed
retrieved: 4 February 2021
Timestamp+2021-02-04T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / instance of: editorial / reference
 
Property / titleProperty / title
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes. (English)
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes (English)
Property / published in: Diabetes Care / reference
 
stated in: PubMed Central
retrieved: 26 October 2022
Timestamp+2022-10-26T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / published in: Diabetes Care / reference
 
stated in: PubMed Central
retrieved: 18 January 2024
Timestamp+2024-01-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / author name string
Ralph A Defronzo
 
Property / author name string: Ralph A Defronzo / rank
Normal rank
 
Property / author name string: Ralph A Defronzo / qualifier
 
Property / author name string: Ralph A Defronzo / reference
stated in: Europe PubMed Central
PubMed publication ID: 21447659
retrieved: 4 August 2017
Timestamp+2017-08-04T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / main subject: type 2 diabetes / reference
 
stated in: PubMed
retrieved: 4 February 2021
Timestamp+2021-02-04T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / main subject: type 2 diabetes / reference
stated in: PubMed
retrieved: 17 September 2019
Timestamp+2019-09-17T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / main subject: type 2 diabetes / reference
stated in: PubMed
retrieved: 2 October 2019
Timestamp+2019-10-02T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / main subject
 
Property / main subject: dopamine / rank
Normal rank
 
Property / main subject
 
Property / main subject: maturity-onset diabetes of the young / rank
Normal rank
 
Property / main subject: maturity-onset diabetes of the young / reference
stated in: PubMed Central
retrieved: 13 March 2019
Timestamp+2019-03-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / main subject: maturity-onset diabetes of the young / reference
stated in: PubMed Central
retrieved: 14 March 2019
Timestamp+2019-03-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / main subject: maturity-onset diabetes of the young / reference
stated in: PubMed
retrieved: 24 March 2019
Timestamp+2019-03-24T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / main subjectProperty / main subject
Property / main subjectProperty / main subject
Property / copyright license: Creative Commons Attribution-NonCommercial-NoDerivatives / reference
 
stated in: PubMed Central
retrieved: 26 October 2022
Timestamp+2022-10-26T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / copyright license: Creative Commons Attribution-NonCommercial-NoDerivatives / reference
 
stated in: PubMed Central
retrieved: 18 January 2024
Timestamp+2024-01-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / publication date
 
April 2011
Timestamp+2011-04-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 month
Before0
After0
Property / publication date: April 2011 / rank
 
Normal rank
Property / publication date: April 2011 / reference
 
Property / title
 
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes (English)
Property / title: Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes (English) / rank
 
Normal rank
Property / title: Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes (English) / reference
 
stated in: Crossref
DOI: 10.2337/DC11-0064
reference URL: https://api.crossref.org/works/10.2337/DC11-0064
retrieved: 28 November 2024
Timestamp+2024-11-28T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / cites work
 
Property / cites work: Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists / rank
 
Normal rank
Property / cites work: Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists / reference
 
stated in: PubMed
reference URL: https://pubmed.ncbi.nlm.nih.gov/21447659
retrieved: 12 December 2020
Timestamp+2020-12-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

based on heuristic: inferred from PubMed ID database lookup
Property / cites work
 
Property / cites work: Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters / rank
 
Normal rank
Property / cites work: Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters / reference
 
stated in: PubMed
reference URL: https://pubmed.ncbi.nlm.nih.gov/21447659
retrieved: 12 December 2020
Timestamp+2020-12-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

based on heuristic: inferred from PubMed ID database lookup
Property / cites work
 
Property / cites work: Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice / rank
 
Normal rank
Property / cites work: Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice / reference
 
stated in: PubMed
reference URL: https://pubmed.ncbi.nlm.nih.gov/21447659
retrieved: 12 December 2020
Timestamp+2020-12-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

based on heuristic: inferred from PubMed ID database lookup
Property / cites work
 
Property / cites work: Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state / rank
 
Normal rank
Property / cites work: Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state / reference
 
stated in: PubMed
reference URL: https://pubmed.ncbi.nlm.nih.gov/21447659
retrieved: 12 December 2020
Timestamp+2020-12-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

based on heuristic: inferred from PubMed ID database lookup
Property / cites work
 
Property / cites work: Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus) / rank
 
Normal rank
Property / cites work: Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus) / reference
 
stated in: PubMed
reference URL: https://pubmed.ncbi.nlm.nih.gov/21447659
retrieved: 12 December 2020
Timestamp+2020-12-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

based on heuristic: inferred from PubMed ID database lookup
Property / cites work
 
Property / cites work: Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation / rank
 
Normal rank
Property / cites work: Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation / reference
 
stated in: PubMed
reference URL: https://pubmed.ncbi.nlm.nih.gov/21447659
retrieved: 12 December 2020
Timestamp+2020-12-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

based on heuristic: inferred from PubMed ID database lookup
Property / author
 
Property / author: Ralph A. DeFronzo / rank
 
Normal rank
Property / author: Ralph A. DeFronzo / qualifier
 
Property / author: Ralph A. DeFronzo / qualifier
 
object named as: Ralph A Defronzo
Property / author: Ralph A. DeFronzo / reference
 
stated in: Europe PubMed Central
PubMed publication ID: 21447659
retrieved: 4 August 2017
Timestamp+2017-08-04T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / author name string
 
Ralph A. Defronzo
Property / author name string: Ralph A. Defronzo / rank
 
Normal rank
Property / author name string: Ralph A. Defronzo / qualifier
 
Property / author name string: Ralph A. Defronzo / reference
 
Property / full work available at URL
 
Property / full work available at URL: https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf / rank
 
Normal rank
Property / full work available at URL: https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf / qualifier
 
Property / full work available at URL: https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf / qualifier
 
Property / full work available at URL: https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf / reference
 
Property / full work available at URL
 
Property / full work available at URL: http://intl-care.diabetesjournals.org/cgi/content/abstract/34/4/789 / rank
 
Normal rank
Property / full work available at URL: http://intl-care.diabetesjournals.org/cgi/content/abstract/34/4/789 / qualifier
 
Property / full work available at URL: http://intl-care.diabetesjournals.org/cgi/content/abstract/34/4/789 / reference
 
Property / full work available at URL
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029 / rank
 
Normal rank
Property / full work available at URL: https://europepmc.org/articles/PMC3064029 / qualifier
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029 / qualifier
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029 / qualifier
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029 / reference
 
Property / full work available at URL
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029?pdf=render / rank
 
Normal rank
Property / full work available at URL: https://europepmc.org/articles/PMC3064029?pdf=render / qualifier
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029?pdf=render / qualifier
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029?pdf=render / qualifier
 
Property / full work available at URL: https://europepmc.org/articles/PMC3064029?pdf=render / reference
 
Property / full work available at URL
 
Property / full work available at URL: https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf / rank
 
Normal rank
Property / full work available at URL: https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf / qualifier
 
Property / full work available at URL: https://diabetesjournals.org/care/article-pdf/34/4/789/608645/789.pdf / reference
 
stated in: Crossref
DOI: 10.2337/DC11-0064
reference URL: https://api.crossref.org/works/10.2337/DC11-0064
retrieved: 28 November 2024
Timestamp+2024-11-28T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Latest revision as of 12:38, 30 November 2024

scientific article published on April 1, 2011
Language Label Description Also known as
English
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
scientific article published on April 1, 2011

    Statements

    title
    Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    21447659
    retrieved
    4 August 2017
    Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes (English)
    1 reference
    stated in
    Crossref
    DOI
    10.2337/DC11-0064
    reference URL
    https://api.crossref.org/works/10.2337/DC11-0064
    retrieved
    28 November 2024
    main subject
    type 2 diabetes
    1 reference
    stated in
    PubMed
    retrieved
    4 February 2021
    bromocriptine
    1 reference
    stated in
    PubMed
    retrieved
    17 September 2019
    dopamine agonist
    1 reference
    stated in
    PubMed
    retrieved
    2 October 2019
    full work available at URL
    cites work

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q34718312&oldid=2281716474"